271 related articles for article (PubMed ID: 29035132)
1. Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier.
d'Angelo I; Costabile G; Durantie E; Brocca P; Rondelli V; Russo A; Russo G; Miro A; Quaglia F; Petri-Fink A; Rothen-Rutishauser B; Ungaro F
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):170-181. PubMed ID: 29035132
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
Conte G; Costabile G; Baldassi D; Rondelli V; Bassi R; Colombo D; Linardos G; Fiscarelli EV; Sorrentino R; Miro A; Quaglia F; Brocca P; d'Angelo I; Merkel OM; Ungaro F
ACS Appl Mater Interfaces; 2022 Feb; 14(6):7565-7578. PubMed ID: 35107987
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
4. Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles.
Comegna M; Conte G; Falanga AP; Marzano M; Cernera G; Di Lullo AM; Amato F; Borbone N; D'Errico S; Ungaro F; d'Angelo I; Oliviero G; Castaldo G
Sci Rep; 2021 Mar; 11(1):6393. PubMed ID: 33737583
[TBL] [Abstract][Full Text] [Related]
5. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
6. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles.
Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M
Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390
[TBL] [Abstract][Full Text] [Related]
8. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
9. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
12. Tunable rigidity of PLGA shell-lipid core nanoparticles for enhanced pulmonary siRNA delivery in 2D and 3D lung cancer cell models.
Wang H; Yuan Y; Qin L; Yue M; Xue J; Cui Z; Zhan X; Gai J; Zhang X; Guan J; Mao S
J Control Release; 2024 Feb; 366():746-760. PubMed ID: 38237688
[TBL] [Abstract][Full Text] [Related]
13. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
[TBL] [Abstract][Full Text] [Related]
14. Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.
Nguyen J; Steele TW; Merkel O; Reul R; Kissel T
J Control Release; 2008 Dec; 132(3):243-51. PubMed ID: 18619502
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-mediated PLGA-PEI Nanobubbles Carrying STAT6 SiRNA Enhances NSCLC Treatment
Shu H; Lv W; Ren ZJ; Li H; Dong T; Zhang Y; Nie F
Curr Drug Deliv; 2024; 21(8):1114-1127. PubMed ID: 37491853
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells.
Gu J; Yang S; Ho EA
Mol Pharm; 2015 Aug; 12(8):2889-903. PubMed ID: 26099315
[TBL] [Abstract][Full Text] [Related]
18. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactide-
Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W
Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
